- ETST
outlined a multiple-year goal of growing a market for its pure, natural extracted
products in the CBD space
- The
company creates proprietary CBD products that are unique to the
nutraceuticals industry
- Its
cutting-edge technology, including its super-critical extraction process,
is designed to create pure and natural hemp oil
Earth Science Tech Inc. (OTCQB: ETST) outlined a
five-year plan in its July 10-K annual report filed with the SEC. The report
details a strategy of creating ETST’s proprietary line of CBD hemp extracts
through a gentle and natural process that utilizes a super-critical extraction
process using CO2 compression, isolation and micron filtration (http://ibn.fm/H330b).
The result is high-grade, CBD-rich hemp oil and other CBD
products that have additional natural molecules. ETST’s highly technical
extraction process creates pure, easily digested, rich CBD hemp oil that’s
unique to the nutraceuticals industry. ETST plans to scale-up its processing
capability to accommodate new products in its pipeline, per the report, and it
aims to make its innovative hemp products available worldwide.
The report also explained that hemp-based CBD is one of at
least 80 cannabinoids found in hemp and is non-psychoactive.
ETST’s U.S.-based operation oversees its supply chain,
including raw material processing, product development and manufacturing, and
sales and marketing. ETST plans to continue expanding its line of supplements
and proprietary CBD-rich hemp oil to broad and diverse channels, including
online, pharmacies, clinics and in-store sales.
ETST is currently sourcing its CBD-rich hemp oil from
high-quality industrial hemp plants grown in Oregon and Kentucky. Referencing
its product’s cultivation, ETST maintains that its CBD-rich hemp oil is
“sourced from the high quality industrial hemp plants grown by generational
family farmers,” and that, throughout the process, the product is lab tested
several times “from seed to shelf” for “cannabinoid panel content, terpenoids,
pesticides, residual solvents, mycotoxins and micros.” This attention to detail
in production quality is a valuable hallmark of ETST’s success, differentiating
it from its competitors.
“We believe that our formulations will set us apart from
competing products for promoting health,” the company stated in the SEC filing.
“We have formulated and produced our initial CBD products, intended for subject
to performance treating various symptoms of diseases and ailments or for
overall health. The company plans to expand manufacturing and marketing of
these CBD products with expansion of products over the next five years.”
ETST is a biotech company focused on the nutraceutical and
pharmaceutical fields. It performs R&D on cannabis and industrial hemp,
markets a line of cannabis products, and maintains a portfolio of diverse subsidiaries.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates
relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
